Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Yayo Biotechnology is a Chinese biotechnology company primarily focused on the research, development, and production of biological products, with a significant emphasis on animal health and veterinary diagnostics. The company operates out of the Haimen Economic and Technological Development Zone and specializes in high-tech biological reagents, vaccines, and diagnostic kits. Their business model integrates R&D with large-scale manufacturing capabilities to serve both domestic and international markets. Jiangsu Yayo is recognized for its contributions to the regional biotech cluster in Jiangsu province, focusing on innovative solutions for disease prevention and control.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Yayo Biotechnology.